

Is Casodex (Bicalutamide) in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your prostate cancer medication.
If you or someone you love takes Casodex (Bicalutamide) for prostate cancer, you may have heard concerns about medication shortages or experienced difficulty filling your prescription. Drug shortages have been a growing problem across the U.S. healthcare system, and it's natural to worry when a medication you depend on seems hard to find.
This article gives you an honest, up-to-date look at the Casodex supply situation in 2026 — including whether there's a real shortage, what's driving availability issues, how much it costs right now, and what steps you can take to make sure you stay on your treatment.
As of early 2026, Bicalutamide is not listed on the FDA Drug Shortage Database. This means there is no officially recognized nationwide shortage of this medication. Generic Bicalutamide 50 mg tablets are manufactured by multiple companies and are generally available through pharmacies and distributors.
However, "not in shortage" and "easy to find at your pharmacy" are not the same thing. Individual pharmacies may be temporarily out of stock due to:
So while the overall supply of Bicalutamide is stable, you may still encounter localized difficulties. If that happens, there are practical solutions — which we'll cover below.
Several factors can make Bicalutamide temporarily hard to find at your local pharmacy, even when there's no nationwide shortage:
Multiple generic manufacturers produce Bicalutamide. If one manufacturer experiences a production delay or quality issue, pharmacies that source from that specific manufacturer may see a temporary gap. Other manufacturers' versions are usually still available, but your pharmacy may need to order from a different supplier.
Chain pharmacies often use automated inventory systems that order medications based on recent prescription patterns. If a store hasn't filled many Bicalutamide prescriptions recently, it may not keep any in stock — even though the medication is readily available from the wholesaler. For a deeper dive into why Casodex is hard to find, see our detailed explainer.
Bicalutamide has seen increased off-label use for conditions such as hirsutism in women, female pattern hair loss, and as part of feminizing hormone therapy. This broader demand can occasionally strain supply at individual locations, particularly smaller pharmacies.
The cost of Casodex depends on whether you're getting the brand name or the generic:
For more ways to reduce your costs, read our complete guide to saving money on Casodex.
The prostate cancer treatment landscape continues to evolve. While Bicalutamide remains a trusted first-line antiandrogen for combined androgen blockade, newer medications have expanded options for patients, especially those with castration-resistant disease:
These medications are not direct replacements for Bicalutamide in most treatment plans but may be options if your cancer has progressed. See our full article on alternatives to Casodex.
If your pharmacy doesn't have Bicalutamide, try these steps:
Read our complete guide on how to find Casodex in stock near you for more tips.
The good news for 2026 is that Bicalutamide is not in a formal FDA-recognized shortage, and its generic version remains widely manufactured and affordable. If you're having trouble finding it at your pharmacy, it's most likely a local stock issue that can be resolved within a day or two.
The most important thing is to not miss doses. Continuous antiandrogen therapy is essential for effective prostate cancer treatment. If you're running low, act early — use Medfinder, contact independent pharmacies, and keep your doctor's office informed so they can help if needed.
For healthcare providers managing patients on Bicalutamide, see our provider shortage briefing for tools and strategies.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.